The ai in patient engagement market size has grown exponentially in recent years. It will grow from $9.28 billion in 2025 to $11.28 billion in 2026 at a compound annual growth rate (CAGR) of 21.6%. The growth in the historic period can be attributed to limited patient engagement tools, reliance on manual health management systems, increasing adoption of electronic health records, growing awareness of patient-centric care, early implementation of chatbots for appointment scheduling.
The ai in patient engagement market size is expected to see exponential growth in the next few years. It will grow to $24.74 billion in 2030 at a compound annual growth rate (CAGR) of 21.7%. The growth in the forecast period can be attributed to advancements in ai and machine learning algorithms, integration of computer vision in patient monitoring, rising investment in digital health infrastructure, increasing focus on personalized patient engagement, expansion of cloud-based healthcare delivery solutions. Major trends in the forecast period include increasing adoption of AI-powered virtual health assistants, rising use of nlp for patient data analysis and sentiment tracking, growth of cloud-based patient engagement platforms, expansion of AI-driven population health management solutions, enhanced remote monitoring and in-patient care through computer vision.
The growing demand for personalized healthcare solutions is expected to drive the expansion of the AI in the patient engagement market in the coming years. Personalized healthcare solutions, also known as personalized medicine, involve customized medical treatments and preventive care strategies that take into account an individual’s medical history, diagnostic results, circumstances, and genetic information. AI in patient engagement supports personalized healthcare by using data analysis and machine learning to customize treatments, predict patient outcomes, and optimize care plans based on individual genetic, lifestyle, and clinical factors. For instance, in February 2024, the Personalized Medicine Coalition, a U.S.-based nonprofit organization, reported that the USFDA approved 16 new personalized treatments for patients with rare diseases in 2023, a notable increase from six personalized treatments approved in 2022. Therefore, the rising demand for personalized healthcare solutions is fueling the growth of the AI in the patient engagement market.
Major companies operating in the AI patient engagement market are developing innovative solutions with advanced technologies, such as AI-powered patient engagement tools, to strengthen their market position. Artificial intelligence patient engagement tools are designed to enhance communication, deliver personalized care, and actively involve patients in managing their health. For instance, in October 2023, ZS Associates, a U.S.-based management consulting firm, launched the AI-powered ZAIDYN Connected Health solution, a comprehensive patient engagement platform that combines AI-driven virtual assistants, personalized messaging, and actionable insights to improve patient care and experience. The platform enables healthcare organizations to scale personalized support across all points of care, ensuring patients receive timely and relevant information and resources.
In July 2024, SAIGroup, a U.S.-based enterprise AI investment firm, acquired Get Well for an undisclosed amount. This acquisition supports SAIGroup’s strategy to expand its presence in AI-driven healthcare solutions. Get Well joins SAIGroup’s portfolio, which also includes ConcertAI (clinical AI and real-world data) and RhythmX AI (personalized care solutions), further strengthening SAIGroup’s leadership in the sector. Get Well is a U.S.-based provider of digital patient engagement solutions for healthcare organizations.
Major companies operating in the ai in patient engagement market are ZS Associates, Health Catalyst, Ada Health GmbH, Zocdoc Inc, Kyruus Inc, Memora Health Inc, HealthLoop Inc, Qventus Inc, Lark Health Inc, Your.MD Ltd, Buoy Health Inc, HealthTap Inc, Welltok Inc, Pillo Health Inc, K Health Inc, Mediktor SL, Clarify Health Solutions Inc, Sensely Inc, Orbita Inc, Clinithink Ltd, WiserCare Inc, Catalia Health Inc, Conversa Health Inc, Prevencio Inc.
North America was the largest region in the AI in patient engagement market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ai in patient engagement market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ai in patient engagement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the AI in patient engagement market by raising costs for imported AI software, cloud infrastructure components, and specialized hardware for computer vision applications. Segments such as NLP tools, cloud-based platforms, and patient monitoring systems are most affected, particularly in north america, europe, and asia-pacific regions that rely on imported technologies. This has led to higher deployment costs and slower adoption in some regions. However, tariffs have encouraged local development of AI solutions, fostering innovation and domestic production capabilities in healthcare technologies.
The ai in patient engagement market research report is one of a series of new reports that provides ai in patient engagement market statistics, including ai in patient engagement industry global market size, regional shares, competitors with a ai in patient engagement market share, detailed ai in patient engagement market segments, market trends and opportunities, and any further data you may need to thrive in the ai in patient engagement industry. This ai in patient engagement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
AI in patient engagement involves the application of artificial intelligence technologies to enhance patient care, improve the overall patient experience, and support health equity. AI can be used in multiple ways to engage patients, including offering digital support and education, automating notifications and reminders, delivering personalized health insights, and analyzing patient data to uncover patterns and improve healthcare delivery.
The primary AI technologies used in patient engagement include chatbots, natural language processing (NLP), and computer vision. A chatbot is an AI-driven software tool created to mimic human interaction, usually through text or voice-based interfaces. These solutions can be deployed using cloud-based or on-premises models. They are applied across various therapeutic areas such as health and wellness, chronic disease management, and others. These technologies support multiple applications including outpatient care management, inpatient care management, population health management, and others, and are utilized by end users such as healthcare providers, payers, and others.
The AI in patient engagement market includes revenues earned by entities by providing services such as patient recommendations, patient sentiments, patient payments, and electronic health record (EHR) analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in patient engagement market also includes sales of mobile devices, wearable devices, sensor devices, and smart home devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The ai in patient engagement market size is expected to see exponential growth in the next few years. It will grow to $24.74 billion in 2030 at a compound annual growth rate (CAGR) of 21.7%. The growth in the forecast period can be attributed to advancements in ai and machine learning algorithms, integration of computer vision in patient monitoring, rising investment in digital health infrastructure, increasing focus on personalized patient engagement, expansion of cloud-based healthcare delivery solutions. Major trends in the forecast period include increasing adoption of AI-powered virtual health assistants, rising use of nlp for patient data analysis and sentiment tracking, growth of cloud-based patient engagement platforms, expansion of AI-driven population health management solutions, enhanced remote monitoring and in-patient care through computer vision.
The growing demand for personalized healthcare solutions is expected to drive the expansion of the AI in the patient engagement market in the coming years. Personalized healthcare solutions, also known as personalized medicine, involve customized medical treatments and preventive care strategies that take into account an individual’s medical history, diagnostic results, circumstances, and genetic information. AI in patient engagement supports personalized healthcare by using data analysis and machine learning to customize treatments, predict patient outcomes, and optimize care plans based on individual genetic, lifestyle, and clinical factors. For instance, in February 2024, the Personalized Medicine Coalition, a U.S.-based nonprofit organization, reported that the USFDA approved 16 new personalized treatments for patients with rare diseases in 2023, a notable increase from six personalized treatments approved in 2022. Therefore, the rising demand for personalized healthcare solutions is fueling the growth of the AI in the patient engagement market.
Major companies operating in the AI patient engagement market are developing innovative solutions with advanced technologies, such as AI-powered patient engagement tools, to strengthen their market position. Artificial intelligence patient engagement tools are designed to enhance communication, deliver personalized care, and actively involve patients in managing their health. For instance, in October 2023, ZS Associates, a U.S.-based management consulting firm, launched the AI-powered ZAIDYN Connected Health solution, a comprehensive patient engagement platform that combines AI-driven virtual assistants, personalized messaging, and actionable insights to improve patient care and experience. The platform enables healthcare organizations to scale personalized support across all points of care, ensuring patients receive timely and relevant information and resources.
In July 2024, SAIGroup, a U.S.-based enterprise AI investment firm, acquired Get Well for an undisclosed amount. This acquisition supports SAIGroup’s strategy to expand its presence in AI-driven healthcare solutions. Get Well joins SAIGroup’s portfolio, which also includes ConcertAI (clinical AI and real-world data) and RhythmX AI (personalized care solutions), further strengthening SAIGroup’s leadership in the sector. Get Well is a U.S.-based provider of digital patient engagement solutions for healthcare organizations.
Major companies operating in the ai in patient engagement market are ZS Associates, Health Catalyst, Ada Health GmbH, Zocdoc Inc, Kyruus Inc, Memora Health Inc, HealthLoop Inc, Qventus Inc, Lark Health Inc, Your.MD Ltd, Buoy Health Inc, HealthTap Inc, Welltok Inc, Pillo Health Inc, K Health Inc, Mediktor SL, Clarify Health Solutions Inc, Sensely Inc, Orbita Inc, Clinithink Ltd, WiserCare Inc, Catalia Health Inc, Conversa Health Inc, Prevencio Inc.
North America was the largest region in the AI in patient engagement market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ai in patient engagement market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ai in patient engagement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the AI in patient engagement market by raising costs for imported AI software, cloud infrastructure components, and specialized hardware for computer vision applications. Segments such as NLP tools, cloud-based platforms, and patient monitoring systems are most affected, particularly in north america, europe, and asia-pacific regions that rely on imported technologies. This has led to higher deployment costs and slower adoption in some regions. However, tariffs have encouraged local development of AI solutions, fostering innovation and domestic production capabilities in healthcare technologies.
The ai in patient engagement market research report is one of a series of new reports that provides ai in patient engagement market statistics, including ai in patient engagement industry global market size, regional shares, competitors with a ai in patient engagement market share, detailed ai in patient engagement market segments, market trends and opportunities, and any further data you may need to thrive in the ai in patient engagement industry. This ai in patient engagement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
AI in patient engagement involves the application of artificial intelligence technologies to enhance patient care, improve the overall patient experience, and support health equity. AI can be used in multiple ways to engage patients, including offering digital support and education, automating notifications and reminders, delivering personalized health insights, and analyzing patient data to uncover patterns and improve healthcare delivery.
The primary AI technologies used in patient engagement include chatbots, natural language processing (NLP), and computer vision. A chatbot is an AI-driven software tool created to mimic human interaction, usually through text or voice-based interfaces. These solutions can be deployed using cloud-based or on-premises models. They are applied across various therapeutic areas such as health and wellness, chronic disease management, and others. These technologies support multiple applications including outpatient care management, inpatient care management, population health management, and others, and are utilized by end users such as healthcare providers, payers, and others.
The AI in patient engagement market includes revenues earned by entities by providing services such as patient recommendations, patient sentiments, patient payments, and electronic health record (EHR) analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in patient engagement market also includes sales of mobile devices, wearable devices, sensor devices, and smart home devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. AI in Patient Engagement Market Characteristics
3. AI in Patient Engagement Market Supply Chain Analysis
4. Global AI in Patient Engagement Market Trends and Strategies
5. AI in Patient Engagement Market Analysis of End Use Industries
7. Global AI in Patient Engagement Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global AI in Patient Engagement Total Addressable Market (TAM) Analysis for the Market
9. AI in Patient Engagement Market Segmentation
10. AI in Patient Engagement Market Regional and Country Analysis
11. Asia-Pacific AI in Patient Engagement Market
12. China AI in Patient Engagement Market
13. India AI in Patient Engagement Market
14. Japan AI in Patient Engagement Market
15. Australia AI in Patient Engagement Market
16. Indonesia AI in Patient Engagement Market
17. South Korea AI in Patient Engagement Market
18. Taiwan AI in Patient Engagement Market
19. South East Asia AI in Patient Engagement Market
20. Western Europe AI in Patient Engagement Market
21. UK AI in Patient Engagement Market
22. Germany AI in Patient Engagement Market
23. France AI in Patient Engagement Market
24. Italy AI in Patient Engagement Market
25. Spain AI in Patient Engagement Market
26. Eastern Europe AI in Patient Engagement Market
27. Russia AI in Patient Engagement Market
28. North America AI in Patient Engagement Market
29. USA AI in Patient Engagement Market
30. Canada AI in Patient Engagement Market
31. South America AI in Patient Engagement Market
32. Brazil AI in Patient Engagement Market
33. Middle East AI in Patient Engagement Market
34. Africa AI in Patient Engagement Market
36. AI in Patient Engagement Market Competitive Landscape and Company Profiles
37. AI in Patient Engagement Market Other Major and Innovative Companies
40. AI in Patient Engagement Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
AI In Patient Engagement Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses ai in patient engagement market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for ai in patient engagement? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ai in patient engagement market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Technology: Chatbots; Natural Language Processing (NLP)2) By Delivery Type: Cloud-Based; On-premise
3) By Therapeutic Area: Health And Wellness; Chronic Disease Management; Other Therapeutic Areas
4) By Application: Outpatient Health Management; Population Health Management; Other Applications
5) By End-Use: Providers; Payers; Other End-Uses
Subsegments:
1) By Chatbots: Virtual Health Assistants; Appointment Scheduling Bots; Symptom Checkers2) By Natural Language Processing (NLP): Text Analysis Tools; Sentiment Analysis Applications; Voice Recognition Systems
Companies Mentioned: ZS Associates; Health Catalyst; Ada Health GmbH; Zocdoc Inc; Kyruus Inc; Memora Health Inc; HealthLoop Inc; Qventus Inc; Lark Health Inc; Your.MD Ltd; Buoy Health Inc; HealthTap Inc; Welltok Inc; Pillo Health Inc; K Health Inc; Mediktor SL; Clarify Health Solutions Inc; Sensely Inc; Orbita Inc; Clinithink Ltd; WiserCare Inc; Catalia Health Inc; Conversa Health Inc; Prevencio Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this AI in Patient Engagement market report include:- ZS Associates
- Health Catalyst
- Ada Health GmbH
- Zocdoc Inc
- Kyruus Inc
- Memora Health Inc
- HealthLoop Inc
- Qventus Inc
- Lark Health Inc
- Your.MD Ltd
- Buoy Health Inc
- HealthTap Inc
- Welltok Inc
- Pillo Health Inc
- K Health Inc
- Mediktor SL
- Clarify Health Solutions Inc
- Sensely Inc
- Orbita Inc
- Clinithink Ltd
- WiserCare Inc
- Catalia Health Inc
- Conversa Health Inc
- Prevencio Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 11.28 Billion |
| Forecasted Market Value ( USD | $ 24.74 Billion |
| Compound Annual Growth Rate | 21.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
